查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1487495

骨科生物製品市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

骨科生物製品市場 - 報告範圍

TMR 關於全球骨科生物製品市場的報告研究了過去和當前的成長趨勢以及機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。 -2031年，以2023年為基準年，2031年為預測年。該報告也提供了2023年至2031年全球骨科生物製品市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解骨科生物製品市場。

市場概況
2022年市場價​​值 62 億美元
2031 年市場價值 103 億美元
複合年成長率 5.7%

該報告深入研究了全球骨科生物製品市場的競爭格局。全球骨科生物製品市場的主要參與者已被確定，並且每位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球骨科生物製品市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031 年全球市場分析與預測

第 5 章：關鍵見解

  • 技術進步
  • 骨科疾病的發生率
  • 監管場景：按主要國家
  • 報銷場景：按主要國家
  • 定價分析
  • 管道分析
  • 最有效組合產品概述
  • COVID-19 大流行影響分析

第 6 章：全球市場分析與預測：依產品分類

  • 簡介與定義
  • 主要發現/進展
  • 2017-2031 年各產品市場價值預測
    • 去礦骨基質 (DBM)
    • 羥基磷灰石 (HAp)
    • 透明質酸（HA）
    • 硫酸鈣基質
    • B-磷酸三鈣（B-TCP）
    • B-TCP+HAp
    • DBM+PLGA
    • 再生醫學
      • 富血小板血漿
      • BMAC
      • SVF
      • 其他（外泌體等）
    • 生長因子
      • 骨形態發生蛋白2
      • 纖維母細胞生長因子2
      • 轉化生長因子BETA
      • 血管內皮生長因子
      • 其他（IGF等）
  • 按產品分類的市場吸引力

第 7 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 2017-2031 年最終用戶市場價值預測
    • 醫院
    • 骨科診所
    • 其他（耳鼻喉科診所等）
  • 最終用戶的市場吸引力

第 8 章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 歐洲
    • 印度
    • 世界其他地區
  • 按國家/地區分類的市場吸引力

第 9 章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第 10 章：印度市場分析與預測

第 11 章：世界其他地區市場分析與預測

第 12 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 公司市佔率分析 (2022)
  • 公司簡介
    • Arthrex, Inc.
    • ATEC Spine, Inc.
    • Bioventus
    • Exactech, Inc.
    • Globus Medical
    • Integra Lifesciences Corporation
    • Johnson & Johnson
    • Medtronic plc
    • MTF Biologics
    • NORAKER
    • RTI Surgical
    • Stryker
    • Zimmer Biomet
Product Code: TMRGL1747

Orthobiologics Market - Scope of Report

TMR's report on the global orthobiologics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global orthobiologics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global orthobiologics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the orthobiologics market.

Market Snapshot
Market Value in 2022US$ 6.2 Bn
Market Value in 2031US$ 10.3 Bn
CAGR5.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global orthobiologics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global orthobiologics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global orthobiologics market.

The report delves into the competitive landscape of the global orthobiologics market. Key players operating in the global orthobiologics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global orthobiologics market profiled in this report.

Key Questions Answered in Global orthobiologics Market Report:

  • What is the sales/revenue generated by orthobiologics across all regions during the forecast period?
  • What are the opportunities in the global orthobiologics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Orthobiologics Market - Research Objectives and Research Approach

The comprehensive report on the global orthobiologics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global orthobiologics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global orthobiologics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Orthobiologics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Orthobiologics Market Analysis and Forecasts, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancements in Orthobiologics
  • 5.2. Incidence of Orthopedic Disorders
  • 5.3. Regulatory Scenario, by Key Countries
  • 5.4. Reimbursement Scenario, by Key Countries
  • 5.5. Pricing Analysis of Orthobiologics
  • 5.6. Pipeline Analysis
  • 5.7. Overview of Most Effective Combinations of Orthobiologics products
  • 5.8. COVID-19 Pandemic Impact Analysis

6. Global Orthobiologics Market Analysis and Forecasts, By Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product, 2017-2031
    • 6.3.1. Demineralized Bone Matrix (DBM)
    • 6.3.2. Hydroxyapatite (HAp)
    • 6.3.3. Hyaluronic acid (HA)
    • 6.3.4. Calcium Sulfate Matrix
    • 6.3.5. B-tricalcium phosphate (B-TCP)
    • 6.3.6. B-TCP + HAp
    • 6.3.7. DBM + PLGA
    • 6.3.8. Regenerative Medicine
      • 6.3.8.1. PRP
      • 6.3.8.2. BMAC
      • 6.3.8.3. SVF
      • 6.3.8.4. Others (Exosome, etc.)
    • 6.3.9. Growth Factors
      • 6.3.9.1. BMP2
      • 6.3.9.2. FGF2
      • 6.3.9.3. TGF beta
      • 6.3.9.4. VEGF
      • 6.3.9.5. Others (IGF, etc.)
  • 6.4. Market Attractiveness By Product

7. Global Orthobiologics Market Analysis and Forecasts, By End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By End-user, 2017-2031
    • 7.3.1. Hospitals
    • 7.3.2. Orthopedic Clinics
    • 7.3.3. Others (ENT Clinics, etc.)
  • 7.4. Market Attractiveness By End-user

8. Global Orthobiologics Market Analysis and Forecasts, By Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast By Region
    • 8.2.1. Europe
    • 8.2.2. India
    • 8.2.3. Rest of the World
  • 8.3. Market Attractiveness By Country/Region

9. Europe Orthobiologics Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast By Product, 2017-2031
    • 9.2.1. Demineralized Bone Matrix (DBM)
    • 9.2.2. Hydroxyapatite (HAp)
    • 9.2.3. Hyaluronic acid (HA)
    • 9.2.4. Calcium Sulfate Matrix
    • 9.2.5. B-tricalcium phosphate (B-TCP)
    • 9.2.6. B-TCP + Hap
    • 9.2.7. DBM + PLGA
    • 9.2.8. B-TCP + PLGA
    • 9.2.9. Regenerative Medicine
      • 9.2.9.1. PRP
      • 9.2.9.2. BMAC
      • 9.2.9.3. SVF
      • 9.2.9.4. Others (Exosome, etc.)
    • 9.2.10. Growth Factors
      • 9.2.10.1. BMP2
      • 9.2.10.2. FGF2
      • 9.2.10.3. TGF beta
      • 9.2.10.4. VEGF
      • 9.2.10.5. Others (IGF, etc.)
  • 9.3. Market Value Forecast By End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Orthopedic Clinics
    • 9.3.3. Others (ENT Clinics, etc.)
  • 9.4. Market Value Forecast By Country, 2017-2031
    • 9.4.1. Germany
    • 9.4.2. U.K.
    • 9.4.3. France
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Rest of Europe
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. India Orthobiologics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product, 2017-2031
    • 10.2.1. Demineralized Bone Matrix (DBM)
    • 10.2.2. Hydroxyapatite (HAp)
    • 10.2.3. Hyaluronic acid (HA)
    • 10.2.4. Calcium Sulfate Matrix
    • 10.2.5. B-tricalcium phosphate (B-TCP)
    • 10.2.6. B-TCP + HAp
    • 10.2.7. DBM + PLGA
    • 10.2.8. B-TCP + PLGA
    • 10.2.9. Regenerative Medicine
      • 10.2.9.1. PRP
      • 10.2.9.2. BMAC
      • 10.2.9.3. SVF
      • 10.2.9.4. Others (Exosome, etc.)
    • 10.2.10. Growth Factors
      • 10.2.10.1. BMP2
      • 10.2.10.2. FGF2
      • 10.2.10.3. TGF beta
      • 10.2.10.4. VEGF
      • 10.2.10.5. Others (IGF, etc.)
  • 10.3. Market Value Forecast By End-user, 2017-2031
    • 10.3.1. Hospitals
    • 10.3.2. Orthopedic Clinics
    • 10.3.3. Others (ENT Clinics, etc.)
  • 10.4. Market Attractiveness Analysis
    • 10.4.1. By Product
    • 10.4.2. By End-user

11. Rest of the World Orthobiologics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product, 2017-2031
    • 11.2.1. Demineralized Bone Matrix (DBM)
    • 11.2.2. Hydroxyapatite (HAp)
    • 11.2.3. Hyaluronic acid (HA)
    • 11.2.4. Calcium Sulfate Matrix
    • 11.2.5. B-tricalcium phosphate (B-TCP)
    • 11.2.6. B-TCP + HAp
    • 11.2.7. DBM + PLGA
    • 11.2.8. B-TCP + PLGA
    • 11.2.9. Regenerative Medicine
      • 11.2.9.1. PRP
      • 11.2.9.2. BMAC
      • 11.2.9.3. SVF
      • 11.2.9.4. Others (Exosome, etc.)
    • 11.2.10. Growth Factors
      • 11.2.10.1. BMP2
      • 11.2.10.2. FGF2
      • 11.2.10.3. TGF beta
      • 11.2.10.4. VEGF
      • 11.2.10.5. Others (IGF, etc.)
  • 11.3. Market Value Forecast By End-user, 2017-2031
    • 11.3.1. Hospitals
    • 11.3.2. Orthopedic Clinics
    • 11.3.3. Others (ENT Clinics, etc.)
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Product
    • 11.4.2. By End-user

12. Competition Landscape

  • 12.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 12.2. Market Share Analysis By Company (2022)
  • 12.3. Company Profiles
    • 12.3.1. Arthrex, Inc.
      • 12.3.1.1. Company Overview
      • 12.3.1.2. Financial Overview
      • 12.3.1.3. Product Portfolio
      • 12.3.1.4. Business Strategies
      • 12.3.1.5. Recent Developments
    • 12.3.2. ATEC Spine, Inc.
      • 12.3.2.1. Company Overview
      • 12.3.2.2. Financial Overview
      • 12.3.2.3. Product Portfolio
      • 12.3.2.4. Business Strategies
      • 12.3.2.5. Recent Developments
    • 12.3.3. Bioventus
      • 12.3.3.1. Company Overview
      • 12.3.3.2. Financial Overview
      • 12.3.3.3. Product Portfolio
      • 12.3.3.4. Business Strategies
      • 12.3.3.5. Recent Developments
    • 12.3.4. Exactech, Inc.
      • 12.3.4.1. Company Overview
      • 12.3.4.2. Financial Overview
      • 12.3.4.3. Product Portfolio
      • 12.3.4.4. Business Strategies
      • 12.3.4.5. Recent Developments
    • 12.3.5. Globus Medical
      • 12.3.5.1. Company Overview
      • 12.3.5.2. Financial Overview
      • 12.3.5.3. Product Portfolio
      • 12.3.5.4. Business Strategies
      • 12.3.5.5. Recent Developments
    • 12.3.6. Integra Lifesciences Corporation
      • 12.3.6.1. Company Overview
      • 12.3.6.2. Financial Overview
      • 12.3.6.3. Product Portfolio
      • 12.3.6.4. Business Strategies
      • 12.3.6.5. Recent Developments
    • 12.3.7. Johnson & Johnson
      • 12.3.7.1. Company Overview
      • 12.3.7.2. Financial Overview
      • 12.3.7.3. Product Portfolio
      • 12.3.7.4. Business Strategies
      • 12.3.7.5. Recent Developments
    • 12.3.8. Medtronic plc
      • 12.3.8.1. Company Overview
      • 12.3.8.2. Financial Overview
      • 12.3.8.3. Product Portfolio
      • 12.3.8.4. Business Strategies
      • 12.3.8.5. Recent Developments
    • 12.3.9. MTF Biologics
      • 12.3.9.1. Company Overview
      • 12.3.9.2. Financial Overview
      • 12.3.9.3. Product Portfolio
      • 12.3.9.4. Business Strategies
      • 12.3.9.5. Recent Developments
    • 12.3.10. NORAKER
      • 12.3.10.1. Company Overview
      • 12.3.10.2. Financial Overview
      • 12.3.10.3. Product Portfolio
      • 12.3.10.4. Business Strategies
      • 12.3.10.5. Recent Developments
    • 12.3.11. RTI Surgical
      • 12.3.11.1. Company Overview
      • 12.3.11.2. Financial Overview
      • 12.3.11.3. Product Portfolio
      • 12.3.11.4. Business Strategies
      • 12.3.11.5. Recent Developments
    • 12.3.12. Stryker
      • 12.3.12.1. Company Overview
      • 12.3.12.2. Financial Overview
      • 12.3.12.3. Product Portfolio
      • 12.3.12.4. Business Strategies
      • 12.3.12.5. Recent Developments
    • 12.3.13. Zimmer Biomet
      • 12.3.13.1. Company Overview
      • 12.3.13.2. Financial Overview
      • 12.3.13.3. Product Portfolio
      • 12.3.13.4. Business Strategies
      • 12.3.13.5. Recent Developments

List of Tables

  • Table 01: Global Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031
  • Table 03: Global Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031
  • Table 04: Global Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Orthobiologics Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: India Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 07: India Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031
  • Table 08: India Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031
  • Table 09: India Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 10: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 11: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 12: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031
  • Table 13: Europe Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031
  • Table 14: Europe Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 16: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by Regenerative Medicine, 2017-2031
  • Table 17: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by Growth Factors, 2017-2031
  • Table 18: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Orthobiologics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Orthobiologics Market Share Analysis, by Product, 2022
  • Figure 03: Global Orthobiologics Market Share Analysis, by End-user, 2022
  • Figure 04: Global Orthobiologics Market Value (US$ Mn) Share Analysis, by Product, 2022 and 2031
  • Figure 05: Global Orthobiologics Market Share Analysis, by Product, 2022
  • Figure 06: Global Orthobiologics Market Share Analysis, by Product, 2031
  • Figure 07: Global Orthobiologics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 08: Global Orthobiologics Market Revenue (US$ Mn), by Demineralized Bone Matrix (DBM), 2017-2031
  • Figure 09: Global Orthobiologics Market Value Share Analysis, by Demineralized Bone Matrix (DBM), 2022 and 2031
  • Figure 10: Global Orthobiologics Market Revenue (US$ Mn), by Hydroxyapatite (HAp), 2017-2031
  • Figure 11: Global Orthobiologics Market Value Share Analysis, by Hydroxyapatite (HAp), 2022 and 2031
  • Figure 12: Global Orthobiologics Market Revenue (US$ Mn), by Hyaluronic acid (HA), 2017-2031
  • Figure 13: Global Orthobiologics Market Value Share Analysis, by Hyaluronic acid (HA), 2022 and 2031
  • Figure 14: Global Orthobiologics Market Revenue (US$ Mn), by Calcium Sulfate Matrix, 2017-2031
  • Figure 15: Global Orthobiologics Market Value Share Analysis, by Calcium Sulfate Matrix, 2022 and 2031
  • Figure 16: Global Orthobiologics Market Revenue (US$ Mn), by B-tricalcium phosphate (B-TCP), 2017-2031
  • Figure 17: Global Orthobiologics Market Value Share Analysis, by B-tricalcium phosphate (B-TCP), 2022 and 2031
  • Figure 18: Global Orthobiologics Market Revenue (US$ Mn), by B-TCP + HAp, 2017-2031
  • Figure 19: Global Orthobiologics Market Value Share Analysis, by B-TCP + HAp, 2022 and 2031
  • Figure 20: Global Orthobiologics Market Revenue (US$ Mn), by DBM + HA, 2017-2031
  • Figure 21: Global Orthobiologics Market Value Share Analysis, by DBM + HA, 2022 and 2031
  • Figure 22: Global Orthobiologics Market Revenue (US$ Mn), by B-TCP + PLGA, 2017-2031
  • Figure 23: Global Orthobiologics Market Value Share Analysis, by B-TCP + PLGA, 2022 and 2031
  • Figure 24: Global Orthobiologics Market Revenue (US$ Mn), by Regenerative medicine, 2017-2031
  • Figure 25: Global Orthobiologics Market Value Share Analysis, by Regenerative medicine, 2022 and 2031
  • Figure 26: Global Orthobiologics Market Revenue (US$ Mn), by Growth Factors, 2017-2031
  • Figure 27: Global Orthobiologics Market Value Share Analysis, by Growth Factors, 2022 and 2031
  • Figure 28: Global Orthobiologics Market Value (US$ Mn) Share Analysis, by End-user, 2022 and 2031
  • Figure 29: Global Orthobiologics Market Share Analysis, by End-user, 2022
  • Figure 30: Global Orthobiologics Market Share Analysis, by End-user, 2031
  • Figure 31: Global Orthobiologics Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 32: Global Orthobiologics Market Value Share Analysis, by Hospitals, 2022 and 2031
  • Figure 33: Global Orthobiologics Market Revenue (US$ Mn), by Orthopedic Clinics, 2017-2031
  • Figure 34: Global Orthobiologics Market Value Share Analysis, by Orthopedic Clinics, 2022 and 2031
  • Figure 35: Global Orthobiologics Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 36: Global Orthobiologics Market Value Share Analysis, by Others, 2022 and 2031
  • Figure 37: Global Orthobiologics Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 38: Global Orthobiologics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 39: India Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 40: India Orthobiologics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 41: India Orthobiologics Market Attractiveness Analysis, Product, 2023-2031
  • Figure 42: India Orthobiologics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 43: India Orthobiologics Market Attractiveness Analysis, End-user, 2023-2031
  • Figure 44: Europe Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 45: Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 46: Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Europe Orthobiologics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 48: Europe Orthobiologics Market Attractiveness Analysis, Product, 2023-2031
  • Figure 49: Europe Orthobiologics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 50: Europe Orthobiologics Market Attractiveness Analysis, End-user, 2023-2031
  • Figure 51: Rest of the World Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 52: Rest of the World Orthobiologics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 53: Rest of the World Orthobiologics Market Attractiveness Analysis, Product, 2023-2031
  • Figure 54: Rest of the World Orthobiologics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 55: Rest of the World Orthobiologics Market Attractiveness Analysis, End-user, 2023-2031
  • Figure 56: Market Share Analysis by Company (2022)